Search results
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 4 days agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 1 day agoIn the past year, Lilly's stock has risen... and Moderna are grappling with declining sales of their...
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 6 days agoThat will depend on regulatory developments, but it's fair to be cautiously optimistic. The biotech...
Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer
Clinical Trials Arena via Yahoo Finance· 2 days agoIn 1980, scientists discovered something rather unexpected – the tuberculosis vaccine, Bacillus...
InnovationRx: Health Officials Brace For West Nile Virus
Forbes· 3 days agoInnovationRx is your weekly digest of healthcare news. Across the United States, health officials...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 4 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 5 days agoThis underperformance of Pfizer stock can be attributed to declining revenues after the surge in Covid-19 vaccine demand during the pandemic. Returning to the pre-inflation ...